Overview
The CT Screening Symposium is a 2-day interactive, immersive, virtual event focused on lung cancer screening technologies and best practices. Using a mix of pre-recorded educational presentations and real-time expert discussions, as well as interactive live Q&A opportunities, the Symposium will address topics relevant to an international audience. Faculty will provide anecdotal experience and review current data to highlight successes and help remove barriers to increased adoption of more uniform and effective lung cancer screening around the world.
- Increase your understanding of the current evidence for lung cancer early detection and screening, as well of international successes and challenges regarding implementation of screening programs
- Learn about treatment approaches for early screening-detected lung cancer and the role of biomarkers
- Interact with experts and colleagues from around the globe via live Q&A periods and chat
- Watch on your time and in real-time
Pre-Meeting Content Now Available
Pre-meeting content is now available on the CT Screening Symposium virtual platform. To access, please use the email address and password provided in your final registration confirmation email.
Program at a Glance
Detailed Program
Overview of the Current Evidence for Lung Cancer Early Detection and Screening
May 7 | 15:05 CET | 9:00 ET
Live Meeting Discussant: David Baldwin
Pre-Meeting Content:
Talk 1: 4ITLR LC Implementation after 10-years NELSON Follow-up Results
Speaker: Harry de Koning
Talk 2: Lessons Learnt from Lung Cancer Screening Studies Worldwide towards Optimal Implementation
Speaker: John Field
Opportunities and Challenges to Advance Lung Cancer Screening Globally (North America)
May 7 | 15:12 CET | 9:12 ET
Live Meeting Discussant: Claudia Henschke
Pre-Meeting Content:
Talk 1: USA: Population Implementation. Report on the First Million Screens in the ACR Lung Cancer Screening Registry
Speaker: Ella Kazerooni
Talk 2: Canada: Organized Screening Programs in Canada
Speaker: Martin Tammemagi
Talk 3: Lung cancer screening in the times of respiratory infections
Speaker: Rudolf Maria Huber
Opportunities and Challenges to Advance Lung Cancer Screening Globally (Asia)
May 7 | 15:20 CET | 9:20 ET
Live Meeting Discussant: Claudia Henschke
Pre-Meeting Content:
Talk 1: Taiwan: Moving Beyond TALENT
Speaker: Pan-Chyr Yang
Talk 2: Japan: outline of screening implementation in Japan
Speaker: Tomio Nakayama
Talk 3: China: The NELCIN B3 trial
Speaker: Li Fan
Talk 4: Korea: Population implementation progress based on K-LUCAS Korean trial
Speaker: Yeol Kim
Opportunities and Challenges to Advance Lung Cancer Screening Globally (Europe)
May 7 | 15:27 CET | 9:27 ET
Live-Meeting Discussant: Ella Kazerooni
Pre-Meeting Content:
Talk 1: England: The NHS Lung Health Checks
Speaker: Philip Crosbie
Talk 2: Italy: The BioMILD and SMILE Study Results
Speaker: Ugo Pastorino
Talk 3: Poland: Interim Results of the National Pilot Lung Cancer Screening Program.
Speaker: Witold Rzyman
Talk 4: France: The IARC Project
Speaker: Hilary Robbins
Talk 5: Croatia: Starting a New Screening Progam from Scratch
Speaker: Ante Marusic
Talk 6: Isreal: A New Lung Cancer Pilot in Soroka Hospital
Speaker: Nir Peled
Talk 7: Russia: Lung Cancer Screening in Russia
Speaker: Victor Gombolevski
Lung Cancer Screening Implementation Methodology
May 7 | 15:42 CET | 9:42 ET
Live Meeting Discussant: Harry de Koning
Pre-Meeting Content:
Talk 1: Quality Control: Phantom Testing and Optimal CT Performance
Speaker: Rick Avila
Talk 2: Acquisition Protocols and Minimal Dos Requirements
Speaker: Marleen Vonder
Talk 3: Reconstruction Protocols Software Vendor Performance
Speaker: Mario Silva
Talk 4: Optimal Diagnostic Decision Algorithms
Speaker: Joan Walter
Talk 5: Screening in the US Post NELSON
Speaker: David Yankelevitz
Talk 6: Diagnostic Workup After Referral
Speaker: David Baldwin
Talk 7: Cost-Effectiveness of European Implementation
Speaker: Kevin ten Haaf
Talk 8: Screening Implementation in Middle - and Low-Income Countries
Speaker: Lucía Viola
Panel Discussion and Live Q&A
May 7 | 15:57 CET | 9:57 ET
Panelists:
David Baldwin, Claudia Henschke, Ella Kazerooni, Harry de Koning, Ugo Pastorino, Matthijs Oudkerk, Stephen Lam
Join the live panel discussion with the meeting chairs and meeting discussants. This panel will cover topics 1-3 and conclude with a Live Q&A.
Staging Committee Perspective and Database Discussion
May 7 | 17:10 CET | 11:22 ET
Presenters: Dr. David Carbone and Dr. Fred Hirsch
This presentation will feature a member of the IASLC Staging Committee and will discuss the Committee's perspective on the IASLC Screening-Detected database and its conjunction with the IASLC Staging Database. This presentation will be followed by a live Q&A.
Live Q&A Discussants: Hisao Asamura, Ugo Pastorino, Stephen Lam, Matthijs Oudkerk
Lung Cancer Early Detection and Screening Tailored to the Population Risk
May 8 | 15:05 CET | 9:05 ET
Live Meeting Discussant: Chris Amos
Pre-Meeting Content:
Talk 1: Ambient Air Pollution Exposures: Individual Lung Cancer Risk Assessment
Speaker: Stephen Lam
Talk 2: Sex Differences in Lung Cancer
Speaker: Marjolein Heuvelmans
Talk 3: Lung Cancer Screening in Patients Who Never Smoked
Speaker: Chris Amos
Patient-centric Health Care and Lung Cancer Screening
May 8 | 15:10 CET | 9:10 ET
Karen Canfell
Pre-Meeting Content:
Talk 1: Health Connect – The New Zealand/Atlantic Canada Cancer Screening Project
Speaker: Michael Partridge
Talk 2: Early Detection of B3 Disease
Speaker: Matthijs Oudkerk
Talk 3: Early Detection of Interstitial and Obstructive Lung Disease
Speaker: Bram van Ginneken
Talk 4: Early Detection of Coronary Artery Calcification
Speaker: Arthur Stillman
Talk 5: Sharing Decision with Primary Care Physicians
Speaker: Jacob Sands
Talk 6: Patient/Advocate Perspective on Lung Cancer Screening
Speaker: Andrea Borondy-Kitts
Treatment of Screening Detected Early Lung Cancer
May 8 | 15:25 CET | 9:25 ET
Live-Meeting Discussant
Pre-Meeting Content:
Talk 1: Lobectomy vs Sublobar Resection
Speaker: Ugo Pastorino
Talk 2: SABR/SBRT and Protontherapy
Speaker: Suresh Senan
Talk 3: New Prospects of Chemoprevention
Speaker: Eva Szabo
Biomarkers
May 8 | 15:35 CET | 9:35 ET
Live Meeting Discussant: Sam Hanash
Pre-Meeting Content:
Talk 1: The Grail Study
Speaker: Same Janes
Talk 2: The Added Value of Biomarkers for Individual Risk Profile
Speaker: Luis Montuenga
Panel Discussion and Live Q&A
May 8 | 15:45 CET | 9:45 EST
Discussants:
Chris Amos, Valerie Rusch, Sam Hanash, Stephen Lam, Ugo Pastorino, Matthijs Oudkerk
Join the live panel discussion with the meeting chairs and meeting discussants. This panel will cover topics 4-7 and conclude with a Live Q&A.
IASLC President Perspective
May 8 | 16:55 | 10:55 ET
IASLC President: Tetsuya Mitsudomi
This presentation will feature IASLC President, Dr. Tetsuya Mitsudomi's perspective on the IASLC Implementation of AI analysis on LDCT indetermined nodules
AI/Big Data/Data Security or Other LDCT Expert Perspectives
May 8 | 17:05 CET | 11:05 ET
Presenter: TBA
This presentation will share an expert's perspective on the security concerns around the use of AI or other LDCT. Followed by a discussion and Live Q&A featuring: Tetsuya Mitsudomi, Matthijs Oudkerk, Stephen Lam and Ugo Pastorino.
Overview of the Current Evidence for Lung Cancer Early Detection and Screening
May 7 | 15:05 CET | 9:00 ET
Live Meeting Discussant: David Baldwin
Pre-Meeting Content:
Talk 1: 4ITLR LC Implementation after 10-years NELSON Follow-up Results
Speaker: Harry de Koning
Talk 2: Lessons Learnt from Lung Cancer Screening Studies Worldwide towards Optimal Implementation
Speaker: John Field
Opportunities and Challenges to Advance Lung Cancer Screening Globally (North America)
May 7 | 15:12 CET | 9:12 ET
Live Meeting Discussant: Claudia Henschke
Pre-Meeting Content:
Talk 1: USA: Population Implementation. Report on the First Million Screens in the ACR Lung Cancer Screening Registry
Speaker: Ella Kazerooni
Talk 2: Canada: Organized Screening Programs in Canada
Speaker: Martin Tammemagi
Talk 3: Lung cancer screening in the times of respiratory infections
Speaker: Rudolf Maria Huber
Opportunities and Challenges to Advance Lung Cancer Screening Globally (Asia)
May 7 | 15:20 CET | 9:20 ET
Live Meeting Discussant: Claudia Henschke
Pre-Meeting Content:
Talk 1: Taiwan: Moving Beyond TALENT
Speaker: Pan-Chyr Yang
Talk 2: Japan: outline of screening implementation in Japan
Speaker: Tomio Nakayama
Talk 3: China: The NELCIN B3 trial
Speaker: Li Fan
Talk 4: Korea: Population implementation progress based on K-LUCAS Korean trial
Speaker: Yeol Kim
Opportunities and Challenges to Advance Lung Cancer Screening Globally (Europe)
May 7 | 15:27 CET | 9:27 ET
Live-Meeting Discussant: Ella Kazerooni
Pre-Meeting Content:
Talk 1: England: The NHS Lung Health Checks
Speaker: Philip Crosbie
Talk 2: Italy: The BioMILD and SMILE Study Results
Speaker: Ugo Pastorino
Talk 3: Poland: Interim Results of the National Pilot Lung Cancer Screening Program.
Speaker: Witold Rzyman
Talk 4: France: The IARC Project
Speaker: Hilary Robbins
Talk 5: Croatia: Starting a New Screening Progam from Scratch
Speaker: Ante Marusic
Talk 6: Isreal: A New Lung Cancer Pilot in Soroka Hospital
Speaker: Nir Peled
Talk 7: Russia: Lung Cancer Screening in Russia
Speaker: Victor Gombolevski
Lung Cancer Screening Implementation Methodology
May 7 | 15:42 CET | 9:42 ET
Live Meeting Discussant: Harry de Koning
Pre-Meeting Content:
Talk 1: Quality Control: Phantom Testing and Optimal CT Performance
Speaker: Rick Avila
Talk 2: Acquisition Protocols and Minimal Dos Requirements
Speaker: Marleen Vonder
Talk 3: Reconstruction Protocols Software Vendor Performance
Speaker: Mario Silva
Talk 4: Optimal Diagnostic Decision Algorithms
Speaker: Joan Walter
Talk 5: Screening in the US Post NELSON
Speaker: David Yankelevitz
Talk 6: Diagnostic Workup After Referral
Speaker: David Baldwin
Talk 7: Cost-Effectiveness of European Implementation
Speaker: Kevin ten Haaf
Talk 8: Screening Implementation in Middle - and Low-Income Countries
Speaker: Lucía Viola
Panel Discussion and Live Q&A
May 7 | 15:57 CET | 9:57 ET
Panelists:
David Baldwin, Claudia Henschke, Ella Kazerooni, Harry de Koning, Ugo Pastorino, Matthijs Oudkerk, Stephen Lam
Join the live panel discussion with the meeting chairs and meeting discussants. This panel will cover topics 1-3 and conclude with a Live Q&A.
Staging Committee Perspective and Database Discussion
May 7 | 17:10 CET | 11:22 ET
Presenters: Dr. David Carbone and Dr. Fred Hirsch
This presentation will feature a member of the IASLC Staging Committee and will discuss the Committee's perspective on the IASLC Screening-Detected database and its conjunction with the IASLC Staging Database. This presentation will be followed by a live Q&A.
Live Q&A Discussants: Hisao Asamura, Ugo Pastorino, Stephen Lam, Matthijs Oudkerk
Lung Cancer Early Detection and Screening Tailored to the Population Risk
May 8 | 15:05 CET | 9:05 ET
Live Meeting Discussant: Chris Amos
Pre-Meeting Content:
Talk 1: Ambient Air Pollution Exposures: Individual Lung Cancer Risk Assessment
Speaker: Stephen Lam
Talk 2: Sex Differences in Lung Cancer
Speaker: Marjolein Heuvelmans
Talk 3: Lung Cancer Screening in Patients Who Never Smoked
Speaker: Chris Amos
Patient-centric Health Care and Lung Cancer Screening
May 8 | 15:10 CET | 9:10 ET
Karen Canfell
Pre-Meeting Content:
Talk 1: Health Connect – The New Zealand/Atlantic Canada Cancer Screening Project
Speaker: Michael Partridge
Talk 2: Early Detection of B3 Disease
Speaker: Matthijs Oudkerk
Talk 3: Early Detection of Interstitial and Obstructive Lung Disease
Speaker: Bram van Ginneken
Talk 4: Early Detection of Coronary Artery Calcification
Speaker: Arthur Stillman
Talk 5: Sharing Decision with Primary Care Physicians
Speaker: Jacob Sands
Talk 6: Patient/Advocate Perspective on Lung Cancer Screening
Speaker: Andrea Borondy-Kitts
Treatment of Screening Detected Early Lung Cancer
May 8 | 15:25 CET | 9:25 ET
Live-Meeting Discussant
Pre-Meeting Content:
Talk 1: Lobectomy vs Sublobar Resection
Speaker: Ugo Pastorino
Talk 2: SABR/SBRT and Protontherapy
Speaker: Suresh Senan
Talk 3: New Prospects of Chemoprevention
Speaker: Eva Szabo
Biomarkers
May 8 | 15:35 CET | 9:35 ET
Live Meeting Discussant: Sam Hanash
Pre-Meeting Content:
Talk 1: The Grail Study
Speaker: Same Janes
Talk 2: The Added Value of Biomarkers for Individual Risk Profile
Speaker: Luis Montuenga
Panel Discussion and Live Q&A
May 8 | 15:45 CET | 9:45 EST
Discussants:
Chris Amos, Valerie Rusch, Sam Hanash, Stephen Lam, Ugo Pastorino, Matthijs Oudkerk
Join the live panel discussion with the meeting chairs and meeting discussants. This panel will cover topics 4-7 and conclude with a Live Q&A.
IASLC President Perspective
May 8 | 16:55 | 10:55 ET
IASLC President: Tetsuya Mitsudomi
This presentation will feature IASLC President, Dr. Tetsuya Mitsudomi's perspective on the IASLC Implementation of AI analysis on LDCT indetermined nodules
AI/Big Data/Data Security or Other LDCT Expert Perspectives
May 8 | 17:05 CET | 11:05 ET
Presenter: TBA
This presentation will share an expert's perspective on the security concerns around the use of AI or other LDCT. Followed by a discussion and Live Q&A featuring: Tetsuya Mitsudomi, Matthijs Oudkerk, Stephen Lam and Ugo Pastorino.
Share
Meeting Chairs
Stephen Lam, MD
Dr. Lam is professor of medicine at the University of British Columbia. He is a respirologist at BC Cancer, a Distinguished Scientist, and the Leon Judah Blackmore Chair in Lung Cancer Research at the BC Cancer Research Center.
Matthijs Oudkerk, MD, PhD
Dr. Oudkerk is a professor of radiology at the University Medical Center Groningen, Netherlands, and principal investigator for radiology of the NELSON Lung Cancer Detection Study.
Ugo Pastorino, MD
Dr. Pastorino is director, Thoracic Surgery Division, Istituto Nazionale Tumori, Milan, Italy, principal investigator of three prospective lung cancer screening trials, and chair of the IASLC’s Screening and Early Detection Committee.
Related Content
